KMDA
Price:
$6.06
Market Cap:
$348.36M
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; VARIZIG for post exposure prophylaxis of varicella; and GLASSIA for intravenous AATD. It also provides KamRho (D) IM for prophylaxis of hemolytic disease of newborns; KamRho (D) IV for immune therm...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2013-05-31
Stock Exchange
NASDAQ
Ticker
KMDA
According to Kamada Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 4.84. This represents a change of 16.60% compared to the average of 4.15 of the last 4 quarters.
The mean historical Current Ratio of Kamada Ltd. over the last ten years is 3.67. The current 4.84 Current Ratio has changed 13.08% with respect to the historical average. Over the past ten years (40 quarters), KMDA's Current Ratio was at its highest in in the March 2021 quarter at 7.97. The Current Ratio was at its lowest in in the December 2022 quarter at 1.84.
Average
3.67
Median
3.36
Minimum
1.84
Maximum
7.13
Discovering the peaks and valleys of Kamada Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 86.65%
Maximum Annual Current Ratio = 7.13
Minimum Annual Increase = -66.24%
Minimum Annual Current Ratio = 1.84
Year | Current Ratio | Change |
---|---|---|
2023 | 3.43 | 86.65% |
2022 | 1.84 | -23.67% |
2021 | 2.41 | -66.24% |
2020 | 7.13 | 62.51% |
2019 | 4.39 | -6.80% |
2018 | 4.70 | 42.76% |
2017 | 3.30 | 16.33% |
2016 | 2.83 | -19.36% |
2015 | 3.51 | 11.11% |
2014 | 3.16 | -12.47% |
The current Current Ratio of Kamada Ltd. (KMDA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.56
5-year avg
3.84
10-year avg
3.67
Kamada Ltd.’s Current Ratio is greater than Lifecore Biomedical, Inc. (1.83), greater than Shuttle Pharmaceuticals Holdings, Inc. (0.22), greater than Cumberland Pharmaceuticals Inc. (1.13), greater than Ironwood Pharmaceuticals, Inc. (3.62), greater than Mallinckrodt plc (2.74), greater than Organogenesis Holdings Inc. (3.09), greater than Lucy Scientific Discovery Inc. (0.38), greater than Alimera Sciences, Inc. (2.79), greater than Agile Therapeutics, Inc. (0.55), less than Guardion Health Sciences, Inc. (16.67), greater than Akanda Corp. (1.41), greater than Evoke Pharma, Inc. (1.44), greater than Collegium Pharmaceutical, Inc. (0.97), greater than Dr. Reddy's Laboratories Limited (1.92), greater than Pacira BioSciences, Inc. (2.25), greater than Perrigo Company plc (2.56), greater than Eagle Pharmaceuticals, Inc. (1.70), greater than ANI Pharmaceuticals, Inc. (2.74), greater than Phibro Animal Health Corporation (3.23), greater than Deciphera Pharmaceuticals, Inc. (4.19), greater than Prestige Consumer Healthcare Inc. (3.56),
Company | Current Ratio | Market cap |
---|---|---|
1.83 | $279.89M | |
0.22 | $3.04M | |
1.13 | $35.25M | |
3.62 | $737.73M | |
2.74 | $4.52M | |
3.09 | $399.81M | |
0.38 | $906.91K | |
2.79 | $301.29M | |
0.55 | $10.43M | |
16.67 | $4.35M | |
1.41 | $2.20M | |
1.44 | $7.28M | |
0.97 | $937.19M | |
1.92 | $13.05B | |
2.25 | $898.99M | |
2.56 | $3.50B | |
1.70 | $6.74M | |
2.74 | $1.14B | |
3.23 | $876.50M | |
4.19 | $2.21B | |
3.56 | $3.89B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kamada Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kamada Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Kamada Ltd.'s Current Ratio?
How is the Current Ratio calculated for Kamada Ltd. (KMDA)?
What is the highest Current Ratio for Kamada Ltd. (KMDA)?
What is the 3-year average Current Ratio for Kamada Ltd. (KMDA)?
What is the 5-year average Current Ratio for Kamada Ltd. (KMDA)?
How does the current Current Ratio for Kamada Ltd. (KMDA) compare to its historical average?